• Radical prostatectomy is one of the most commonly performed procedures in urological 2 oncology thus affecting a tremendous amount of patients. 3
• To our best knowledge, this will be the first systematic review and meta-analysis comparing 4 interrupted versus continuous suturing for vesicourethral anastomosis during radical 5 prostatectomy. 6
• Subgroup analysis will differentiate between different surgical approaches in order to address 7 a holistic but detailed overview for the individual patient. 8
• The reporting of outcome parameters might be variable among studies. Therefore, it remains 9
to be determined what outcomes are feasible for pooling of the data. 10
• Quality assessment of included studies will provide an overview of the strength of evidence 11 for each outcome. Prostate cancer (PCa) is the most frequently-occurring cancer among men worldwide [1, 2] , with a 2 cancer-specific mortality of about two to three percent in the western world [3, 4] . The mainstay of 3 curative treatment, besides radiotherapy, is radical prostatectomy (RP). RP is chosen as primary 4 treatment in about 50 percent of patients, compared to 25 percent who choose some kind of 5 radiotherapy [5] . 6 During the last two decades different surgical approaches to RP including open, laparoscopic (LRP) 7 and robotic-assisted prostatectomy (RARP) were established. These have been shown to be 8 comparable with regards to oncological outcome, postoperative complications and continence [6] [7] [8] . 9
Despite its effectiveness, RP remains a challenging procedure with a high impact on the patient's life 10 including continence, erectile function and quality of life. 11
The vesicourethral anastomosis (VUA) is a crucial and challenging step of RP even in the hands of 12 experienced surgeons [9, 10] . Although the quality of the VUA is unlikely to have an impact on 13 oncological outcome, it strongly affects functional outcome and thus quality of life [11] . Notably, 14
VUA leakage was found to be the predominant risk factor for postoperative incontinence [12] . 15
Furthermore, VUA quality possibly influences the development of postoperative vesicourethral 16 anastomotic stenosis (VUAS), which occurs in around 2.1-7.5 percent of patients [13] [14] [15] . 17
The suture technique, specifically interrupted (IS) versus continuous suturing (CS), might influence 18 the outcome of the VUA. In general, CS is usually faster and associated with a lower leakage rate [16, 19 17] . On the other side, CS raises concerns for a higher incidence of strictures [18] . 20
Currently, there is a lack of clear evidence concerning a conceivable superiority of IS or CS for VUA. 21
Therefore, the aim of this systematic review and potential meta-analysis will be to compare different 22 suture techniques for VUA in patients undergoing RP. The protocol of the planned systematic review and potential meta-analysis is written in line with the 2 PRISMA-P 2015 checklist [19] . Additionally, the systematic review and meta-analysis was registered 3 with the international prospective register of systematic reviews PROSPERO 4 (CRD42017076126) [20] . 5
Search methodology 6
A systematic literature search will be conducted according to the PICO criteria [21] . In order to 7 retrieve as much evidence as possible, the search will include MESH terms and free text combined 8 with Boolean operators. The search will include synonyms of the following terms: single suture / 9 continuous suture / vesicourethral / anastomosis / prostatectomy / barbed. A previous screening of 10 relevant articles will help to identify synonyms for suture techniques and further relevant key words 11 (e.g. vesicourethral vs. urethrovesical or single suture vs. interrupted suture). 12
The combined search term will be modified for each database and applied to MEDLINE (via 13 PubMed), Embase, Web of Science and the Cochrane Central Register of Controlled Trails 14 (CENTRAL) and ClinicalTrials.gov. By this approach, published, unpublished, and ongoing trails will 15 be detected. After removing all duplicates, the remaining articles will be uploaded to convidence.org 16 [22] . Furthermore, the reference section of all included articles and previous reviews will be searched 17 manually, and experts will be consulted to identify additional literature. In case of missing data, the 18 corresponding authors will be contacted directly. 19
Study selection and data extraction 20
Two researchers will independently screen title and abstract of each article. If considered eligible, the 21 full text will be retrieved and reviewed for eligibility again. Potential disagreement in one of those 22 steps will be solved by consensus and, if necessary, with the help of a third reviewer. This process will 23 be documented in detail in order to create a PRISMA flow diagram. 24
Eligibility criteria 25
Studies are considered eligible if they compare IS versus CS. All types of studies will be included 26 (RCT, non-RCT, observational studies). No language restrictions will be applied. If needed, studies 27 will be translated by professional translators. 28
Exclusion criteria 29
Studies which focus on experiments and operations on animals, models or cadavers will be excluded. 30
Additionally, if a posterior reconstruction was done previously to the VUA in one study group only, 31 these studies or groups will be excluded from analysis. Posterior reconstruction has a potential impact 32 on the operative outcome which was investigated elsewhere [23] . Furthermore, studies with no 33 F o r p e e r r e v i e w o n l y 6 comparison group or none of the defined outcome measures analyzed will be excluded. Studies 1 reporting a perineal approach for RP, an indication for RP other than PCa, or salvage RP will be 2 excluded. 3
Data extraction 4
All extracted data will be filled in a dedicated data sheet (Microsoft Excel™, Redmond, Washington, 5 USA). The data sheet will then be tested on five studies to prove its suitability. Two reviewers will 6 extract the data independently from each other. The following information will be retrieved: 7 1) Methods: authors, year of publication, journal, type of study, country, registration of 8 The primary endpoint will be catheterization time. Secondary endpoints will include rate of 23 extravasation, urinary incontinence at 3, 6 and 12 months postoperatively, development of VUAS, 24 length of hospital stay and time to perform the VUA intraoperatively. 25
Subgroup analysis 26
In order to evaluate the best surgical option for VUA, various comparisons of suture techniques and 27 surgical approach will be performed. The following subgroup analysis will be done if the extracted 28 data appears suitable: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Quality assessment 3
Quality assessment of RCTs will be done with the help of the Cochrane Collaboration's tool for 4 assessing risk of bias in randomized trials [24] . This tool incorporates the following seven domains: a) 5
Random sequence generation, b) Allocation concealment, c) Blinding of participants and personnel, d) 6
Blinding of outcome assessment, e) Selective reporting and f) Anything else, ideally prespecified (e.g. 7 funding). All these domains can be rated as either high, low or unclear. 8
Quality assessment of all non-RCTs will be done with the Newcastle-Ottawa Scale for assessing 9 quality of nonrandomized studies in meta-analyses [25] . Three domains a) selection, b) comparability 10 and c) exposure will be rated with a maximum total score of nine stars. 11
Congress abstracts and further material which can be considered as 'grey literature', will be rated with 12 the lowest possible quality. This literature will be reported separately and not included in statistical 13
testing. 14

Quality of evidence 15
The strength of the body of evidence for relevant endpoints will be assessed using the Grading of 16
Recommendations Assessment, Development and Evaluation (GRADE) tool [26] . According to 17 GRADE the quality of evidence can be rated as high, moderate, low and very low. 18
Statistical analysis 19
In case the extracted data is appropriate for pooled analyses (e.g. similar techniques and patients) a 20 meta-analysis will be performed. Dichotomous data will be analyzed using the Mantel-Haenszel 21 model and reported as odds ratio. In case of continuous data, inverse variance models will be used and 22 reported as mean difference. Forest plots will be used for visualization of the results. 23
The heterogeneity of studies will be calculated using the I² index. An I 2 value of 0 -25 % represents 24 insignificant heterogeneity; > 25 % -50 % low heterogeneity; > 50 % -75 % moderate heterogeneity; 25 and > 75 % high heterogeneity [27] . Insignificant heterogeneity will be calculated using a fixed-effects 26 model and with a low or moderate heterogeneity using a random-effects model. If concerns for high 27 heterogeneity exist, a sensitivity analysis will be performed. In case of a different reporting pattern, 28 mean and standard deviation values (e.g. trials reporting median and range/interquartile range) will be 29 transformed according to Hozo et al. and Higgins et al. [28, 29] . Funnel plots will be used to visualize 30 publication bias. For other bias, a risk of bias assessment figure will be used. For all calculations, the 31 this high volume, even small differences in surgical outcomes can possibly affect a great number of 4 patients. Therefore, we aim to increase the level of evidence concerning the optimal suture techniques 5 for VUA. Our results might help to further standardize the procedure and to optimize functional 6 outcome of patients undergoing RP for PCa. 7
In our analyses, the time until removal of the urinary catheter will be used as the primary outcome, as 8 it is also a direct indicator for length of hospital stay and might has a positive influence in continence 9
[32]. Furthermore, it is likely to be stated in the majority of studies, as its assessment is simple and 10 thus little differences between the included studies are expected. In contrast, continence level or 11 quality of life are commonly measured by different scores making comparison more difficult [33, 34] . 12
Whereas the prevailing aim of the study is to assess differences between IS and CS for VUA in 13 general, subgroup analysis might help to identify the optimal combinations of technique and surgical 14 approach (open vs. LRP/RARP). In case of low sample sizes, the studies will be cumulated and 15 subgroup analysis will only be performed if meaningful. 16
Following the "best evidence approach" and in order to gather all existing literature, we chose to 17 include not only RCTs but also non-RCTs and observational studies. Whether non-RCTs should be 18 included in systematic reviews and meta-analyses is controversial. Some argue that only RCTs provide 19 the highest scientific quality [35] . Without appropriate randomization, studies are prone to 20 confounding bias and to over-or underestimate the effect of interest [29] . In contrast, randomization is 21 not feasible for some research questions [36, 37] . Besides, observational studies might reflect daily 22 clinical work in a more realistic way [38] . Moreover, grey literature (e.g. congress presentations, 23 registered trials) is generally considered as poor quality because detailed information on methodology 24 and randomization are often impossible to reconstruct. Nonetheless, grey literature can be important 25 because it often contains results which were not published since they did not show significant findings 26 and could therefore address publication bias [39, 40] . In order to provide a holistic overview, grey 27 literature will be included but marked as such. In addition, it will not be part of the meta-analysis, and 28 conclusions will be drawn extremely carefully. Finally, the comprehensive literature search will also 29 help to detect alternative surgical strategies which are not commonly used and could be of interest for 30 future research. 31
In summary, the systematic review and meta-analysis will help to determine if there is any difference 32 in CS or IS for VUA and if one technique is superior to the other. Furthermore, quality assessment of 33 the included studies will yield if further well-designed studies are necessary. 34 
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METHODS
Eligibility criteria 8
Specify the study characteristics (e.g., PICO, study design, setting, time frame) and report characteristics (e.g., years considered, language, publication status) to be used as criteria for eligibility for the review p. 5, ll. 25-28
Information sources 9 Describe all intended information sources (e.g., electronic databases, contact with study authors, trial registers, or other grey literature sources) with planned dates of coverage p.5, ll. 13-19
Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated p. 9, ll. 26ff
STUDY RECORDS
Data management 11a Describe the mechanism(s) that will be used to manage records and data throughout the review p. 5, ll. 16-17 p. 6, ll. 4-7
Selection process 11b State the process that will be used for selecting studies (e.g., two independent reviewers) through each phase of the review (i.e., screening, eligibility, and inclusion in meta-analysis) p. 5, ll. 20-24
Data collection process 11c Describe planned method of extracting data from reports (e.g., piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators p. 5, ll. 20-24
Data items 12
List and define all variables for which data will be sought (e.g., PICO items, funding sources), any pre-planned data assumptions and simplifications p. 6, ll. 7-19
Outcomes and prioritization 13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale p. 6, ll. 22-25
Risk of bias in individual studies 14
Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis p. 7, ll. 3-18 Radical prostatectomy is the mainstay of treatment for prostate cancer. The vesicourethral anastomosis 3 is a critical step, which most likely impacts urinary continence and urethral stenosis. To date, it still 4 remains unclear whether interrupted and continuous suturing for the anastomosis have different 5 outcomes. Therefore, the aim of this systematic review and meta-analysis is to compare different 6 suture techniques for vesicourethral anastomosis in terms of surgical and functional parameters. 7
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Methods and Analysis 8
A comprehensive literature search will be conducted covering MEDLINE, Embase, Web of Science, 9
the Cochrane Central Register of Controlled Trails (CENTRAL) and ClinicalTrials.gov. Studies 10 comparing interrupted versus continuous suturing will be included in the analyses. No language 11
restrictions will be applied. Screening, data extraction, statistical analysis and reporting will be done in 12 line with the PRISMA guidelines. Quality assessment will be performed with the help of the Cochrane 13
Collaboration's tool for assessing risk of bias and the Newcastle-Ottawa Scale for assessing quality of 14 nonrandomized studies. The quality of evidence will be evaluated with the Grading of 15
Recommendations Assessment, Development and Evaluation (GRADE). The primary outcome will be 16 the time until removal of the urinary catheter. Secondary outcomes include rate of extravasation, 17 length of hospital stay, time needed to perform the anastomosis, continence level at defined 18 postoperative intervals and development of urethral strictures. Quantitative analysis will be calculated 19 if meaningful. 20
Ethics and dissemination 21
In order to meet the highest ethical and methodological standards we followed the Preferred Reporting 22
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The vesicourethral anastomosis (VUA) is a crucial and challenging step of RP even in the hands of 12 experienced surgeons [9, 10] . Although the quality of the VUA is unlikely to have an impact on 13 oncological outcome, it strongly affects functional outcome and thus quality of life [11] . Notably, 14 VUA leakage was found to be the predominant risk factor for postoperative incontinence [12] . 15
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The combined search term will be modified for each database and applied to MEDLINE (via 13 PubMed), Embase, Web of Science and the Cochrane Central Register of Controlled Trails 14 (CENTRAL) and ClinicalTrials.gov. By this approach, published, unpublished, and ongoing trails will 15 be detected. After removing all duplicates, the remaining articles will be uploaded to convidence.org 16
[22]. Furthermore, the reference section of all included articles and previous reviews will be searched 17 manually, and experts will be consulted to identify additional literature. In case of missing data, the 18 corresponding authors will be contacted directly. 19
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Additionally, if a posterior reconstruction was done previously to the VUA in one study group only, 31 these studies or groups will be excluded from analysis. Posterior reconstruction has a potential impact 32 on the operative outcome which was investigated elsewhere [23] . Furthermore, studies with no 33
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